Effects of anti-TNF therapy on glucose metabolism in patients with ankylosing spondylitis, psoriatic arthritis or juvenile idiopathic arthritis

Biologicals

Volumn 38, Issue 5, 2010, Pages 567-569

  da Silva, Bárbara Santos Pires ^a   Bonfá, Eloísa ^b   de Moraes, Júlio César Bertacini ^b   Saad, Carla Gonçalves Schain ^b   de Medeiros Ribeiro, Ana Cristina ^b   Gonçalves, Célio Roberto ^b   de Carvalho, Jozélio Freire ^b  

^a MASTERS AND DOCTORAL PROGRAMS IN PHYSICAL THERAPY   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti TNF; Biologicals; Glucose; Spondyloarthropathies; Tumoral necrosis factor

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; CORTICOSTEROID; ETANERCEPT; GLUCOCORTICOID; GLUCOSE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; DRUG EFFECT; DRUG USE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; TREATMENT DURATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, PSORIATIC; BLOOD GLUCOSE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956227012     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2010.05.003     Document Type: Article

References (21)

1. Saklatvala J. Tumor necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986, 322:547-549.
2. Martin P., Medeiros A.C., Goldenstein-Schainberg C. O papel dos inibidores do fator de necrose tumoral no tratamento da artrite idiopática juvenil - revisão de literatura. Rev Bras Reumatol 2006, 46:126-133.
3. Olsen N.J., Stein M.C. New drugs for rheumatoid arthritis. N Eng J Med 2004, 350:2167-2179.
4. Sidiropoulos P.I., Karvounaris S.A., Boumpas D.T. Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications. Arthritis Res Ther 2008, 10:207.
5. Gonzalez-Gay M.A., De Matias J.M., Gonzalez-Juanatey C., Garcia-Porrua C., Sanchez-Andrade A., Martin J., et al. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 2006, 24:83-86.
6. Petty R.E., Southwood T.R., Manners P., Baum J., Glass D.N., Goldenberg J., et al. International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004, 31:390-392.
7. Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991, 34:1218-1227.
8. Moll J.M., Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973, 3:55-78.
9. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
10. Gimeno R.E., Klaman L.D. Adipose tissue as an active endocrine organ: recent advances. Curr Opin Pharmacol 2005, 5:122-128.
11. Hotamisligil G.S., Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994, 43:1271-1278.
12. Hotamisligil G.S., Murray D.L., Choy L.N., Spiegelman B.M. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994, 91:4854-4858.
13. Saghizadeh M., Ong J.M., Garvey W.T., Henry R.R., Kern P.A. The expression of TNF-alpha by human muscle. Relationship to insulin resistance. J Clin Invest 1996, 97:1111-1116.
14. Feingold K.R., Marshall M., Gulli R., Moser A.H., Grunfeld C. Effect of endotoxin and citokynes on lipoprotein lipase activity in mice. Arterioscler Thromb 1994, 14:1866-1872.
15. Stephens J.M., Pekala P.H. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem 1991, 266:21839-21845.
16. Zhang B., Berger J., Hu E., Szalkowski D., White-Carrington S., Spiegelman B.M., et al. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol Endocrinol 1996, 10:1457-1466.
17. Bruun J.M., Lihn A.S., Verdich C., Pedersen S.B., Toubro S., Astrup P., et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003, 285:E527-E533.
18. Matsuzawa Y., Funahashi T., Kihara S., Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004, 24:29-33.
19. Ahima R.S., Flier J.S. Leptin. Ann Rev Physiol 2000, 62:413-437.
20. van der Poll T., Romijn J.A., Endert E., Borm J.J., Buller H.R., Sauerwein H.P. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 1991, 261:E457-E465.
21. Clore J.N., Thurby-Hay L. Glucocorticoid-Induced hyperglycemia. Endocr Pract 2009, 6:1-19.